midpage
Projects
Sign in to see your projects.
209 F. Supp. 3d 98
D.D.C.
2016
Read the full case

Background

  • Plaintiffs (Kort, Kovnat, Hepburn) exhibit cognitive impairment and seek Medicare coverage for beta‑amyloid PET scans (BA Scans) that can help exclude Alzheimer’s disease; BA Scans were FDA‑approved for that use.
  • CMS issued a National Coverage Determination (NCD) denying Medicare coverage for BA Scans (except in limited clinical studies), concluding evidence was insufficient to show BA Scans improve health outcomes or inform patient management.
  • Lilly (manufacturer of the Amyvid tracer) requested national Medicare coverage after FDA approval; CMS held public comment periods, convened MEDCAC, issued a Proposed Decision Memo, and then the final Decision Memo denying coverage.
  • Plaintiffs sued under the Administrative Procedure Act (APA), arguing CMS’s coverage standard (requiring evidence of improved health outcomes/disease management even for diagnostic tests) conflicts with the Medicare Act and is inconsistently applied (especially compared to CMS’s prior coverage of FDG PET scans).
  • The district court reviewed the administrative record under Chevron and the arbitrary‑and‑capricious standard and concluded CMS’s reliance on health‑outcomes/patient‑management evidence was permissible under the Medicare Act but that CMS failed to adequately explain its disparate treatment of BA Scans vs. FDG PET.
  • Remedy: cross‑motions for summary judgment granted in part and denied in part; the NCD was remanded to CMS for further proceedings limited to the identified defect (no vacatur of the NCD).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the Medicare Act precludes CMS from requiring diagnostic tests to show improved health outcomes/disease management The statute’s disjunctive “diagnosis or treatment” means diagnostic value alone must suffice for coverage “Reasonable and necessary” is broad; CMS reasonably may consider outcomes/management when deciding coverage Court: Chevron Step 1 — statute does not bar CMS from considering outcomes/management; agency discretion upheld
Whether CMS’s coverage standard (requiring outcomes/management evidence) is arbitrary and capricious CMS misapplied its standard inconsistently and treated BA Scans differently than similar diagnostics CMS relied on relevant literature and expert panels; its standard is supported by reasoned analysis Court: CMS’s overall standard is permissible, but application here was arbitrary in at least one respect (see FDG PET comparison)
Whether CMS treated similarly situated tests (FDG PET) inconsistently without reasoned explanation FDG PET was covered despite lack of studies showing impact on outcomes; denying BA Scans on that basis is arbitrary FDG PET is a fundamentally different technology (measures metabolism vs amyloid burden) and prior expert consensus supported FDG PET Held: CMS failed to provide an adequate explanation reconciling coverage of FDG PET with denial of BA Scans; arbitrary and capricious → remand required
Whether the Decision Memo is internally inconsistent (e.g., acknowledges negative BA Scan "virtually excludes" Alzheimer’s yet denies coverage) Concession that a negative scan ‘‘virtually excludes’’ Alzheimer’s implies diagnostic value that should affect management/outcomes and thus require coverage Statements were hypothetical/qualified; CMS examined harms and concluded evidence did not show improved outcomes/management Held: No internal inconsistency sufficient to overturn the decision; CMS’s qualified statements do not compel coverage given record conclusions

Key Cases Cited

  • Chevron U.S.A. Inc. v. Natural Resources Defense Council, 467 U.S. 837 (1984) (framework for judicial review of agency statutory interpretations)
  • Heckler v. Ringer, 466 U.S. 602 (1984) (agency discretion in determining Medicare "reasonable and necessary")
  • Williams Natural Gas Co. v. FERC, 943 F.2d 1320 (D.C. Cir. 1991) (broad delegation where statute does not define "reasonable" or "necessary")
  • Hays v. Sebelius, 589 F.3d 1279 (D.C. Cir. 2009) (interpretation of Medicare coverage language and limits on Secretary's authority)
  • Motor Vehicle Mfrs. Ass’n v. State Farm Mut. Auto. Ins. Co., 463 U.S. 29 (1983) (arbitrary and capricious standard requires reasoned explanation)
  • County of Los Angeles v. Shalala, 192 F.3d 1005 (D.C. Cir. 1999) (agency must adequately explain treating similar situations differently)
  • Burlington N. & Santa Fe Ry. Co. v. Surface Transp. Bd., 403 F.3d 771 (D.C. Cir. 2005) (arbitrary to apply different standards to similarly situated entities without reasoned explanation)
  • Citizens to Preserve Overton Park v. Volpe, 401 U.S. 402 (1971) (post hoc rationalizations are inadequate to sustain agency action)
  • Allied‑Signal, Inc. v. NRC, 988 F.2d 146 (D.C. Cir. 1993) (remand is appropriate where agency decision has legal error but vacatur discretionary)
Read the full case

Case Details

Case Name: Smith v. Burwell
Court Name: District Court, District of Columbia
Date Published: Jul 19, 2016
Citations: 209 F. Supp. 3d 98; 2016 U.S. Dist. LEXIS 93630; Civil Action No. 2014-1519
Docket Number: Civil Action No. 2014-1519
Court Abbreviation: D.D.C.
Log In
    Smith v. Burwell, 209 F. Supp. 3d 98